Gregory Wickham

Gregory Wickham is a Postdoctoral Research Scientist at Quadram Institute since February 2022, following a Ph.D. candidacy at the same institution from September 2017 to December 2021. Concurrently, Gregory was engaged in an industrial partnership with Procter & Gamble during the Ph.D. program. Gregory completed a PhD in Biological Sciences with a focus on Microbial Genomics at the University of East Anglia in 2021. Prior academic achievements include an MSc in Medical Microbiology with Distinction from The University of Manchester and a BSc (Hons) in Biology with First Class honors from the University of Chester.